Search
Filter Results
Displaying 201–210 of 749 for “retinal diseases”
-
-
Dec 7, 2018
FDA Authorizes Clinical Trial for CRISPR/Cas9 Therapy for LCA 10
Research NewsEditas Medicine, a company developing gene-editing treatments, has received authorization from the US Food and Drug Administration to launch a clinical trial for its emerging CRISPR/Cas9 therapy for people with a mutation in the gene CEP290, which causes Leber congenital amaurosis 10 (LCA10). LCA causes severe vision loss or blindness at birth.
-
DiseaseChoroideremia is an inherited retinal disease that causes progressive vision loss due to degeneration of the choroid, the retinal pigment epithelium or RPE, and the photoreceptors.
-
Apr 14, 2015
Need-to-Know Information about Clinical Trials
Research NewsA primer on what you can expect from clinical trials.
-
Feb 18, 2013
Research NewsMore good news about treatments and technological advances for restoring vision for people with retinal diseases.
-
Oct 2, 2026
Early clinical trial results show vision gains in patients with BEST1-related disease
Research NewsOpus Genetics looks ahead to a Phase 3 trial for its potential gene therapy OPGx-BEST1
-
Nov 8, 2023
Kiora Reports Vision Restoration in Phase 1/2 Clinical Trial for Photoswitch Therapy
Research NewsThe company’s molecule is designed to restore some vision to people with ultra-low or no vision caused by advanced retinitis pigmentosa and other retinal diseases.
-
May 10, 2021
Research NewsPrecise and Sensitive Outcome Measures are Essential for Getting Vision Treatments through Clinical Trials
-
Jun 6, 2025
Research NewsPatients have reported life-changing vision improvements after treatment in the Phase 3 LUMEOS trial.
-
The Llura Liggett Gund Award is the highest honor presented by the Foundation Fighting Blindness, recognizing individuals whose careers have driven extraordinary progress toward treatments and cures for blinding diseases.